A platform for the remote conduct of gene-environment interaction studies.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 3548886)

Published in PLoS One on January 18, 2013

Authors

John Gallacher1, Rory Collins, Paul Elliott, Stephen Palmer, Paul Burton, Clive Mitchell, Gareth John, Ronan Lyons

Author Affiliations

1: Institute of Primary Care and Public Health, Cardiff University, Cardiff, United Kingdom. Gallacher@cf.ac.uk

Articles cited by this

Genes, environment and the value of prospective cohort studies. Nat Rev Genet (2006) 4.33

Web-based questionnaires: the future in epidemiology? Am J Epidemiol (2010) 4.15

The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak (2009) 4.05

New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85

What makes UK Biobank special? Lancet (2012) 3.72

Epidemiology and the internet. Epidemiology (1997) 3.48

Feasibility of using web-based questionnaires in large population-based epidemiological studies. Eur J Epidemiol (2006) 2.86

What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ (2005) 2.50

When epidemiology meets the Internet: Web-based surveys in the Millennium Cohort Study. Am J Epidemiol (2007) 2.41

Comparison between web-based and paper versions of a self-administered anthropometric questionnaire. Eur J Epidemiol (2010) 1.90

The Nutrinet-Santé Study: a web-based prospective study on the relationship between nutrition and health and determinants of dietary patterns and nutritional status. BMC Public Health (2010) 1.88

Comparing web and mail responses in a mixed mode survey in college alcohol use research. Addict Behav (2006) 1.65

Cohort profile: the Danish Web-based Pregnancy Planning Study--'Snart-Gravid'. Int J Epidemiol (2008) 1.62

A successful implementation of e-epidemiology: the Danish pregnancy planning study 'Snart-Gravid'. Eur J Epidemiol (2010) 1.57

Optimizing the design of web-based questionnaires--experience from a population-based study among 50,000 women. Eur J Epidemiol (2007) 1.51

Random allocation in observational data: how small but robust effects could facilitate hypothesis-free causal inference. Epidemiology (2011) 1.38

LifeGene--a large prospective population-based study of global relevance. Eur J Epidemiol (2010) 1.38

Web-based survey attracted age-biased sample with more severe illness than paper-based survey. J Clin Epidemiol (2009) 1.18

Birth outcomes following treatment for precancerous changes to the cervix: a population-based record linkage study. BJOG (2011) 0.98

Achieving online consent to participation in large-scale gene-environment studies: a tangible destination. J Med Ethics (2011) 0.97

Epidemiology of healthy ageing and the idea of more refined outcome measures. Int J Epidemiol (2011) 0.94

The case for large scale fungible cohorts. Eur J Public Health (2007) 0.81

Articles by these authors

(truncated to the top 100)

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09

Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet (2008) 25.83

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet (2008) 20.66

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet (2003) 17.34

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (2007) 15.27

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet (2011) 13.10

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet (2005) 12.92

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet (2009) 11.81

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Major lipids, apolipoproteins, and risk of vascular disease. JAMA (2009) 10.58

Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med (2014) 9.25

Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet (2011) 9.07

Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med (2009) 8.73

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet (2008) 7.33

Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet (2013) 7.25

The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet (2009) 6.39

Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet (2008) 6.06

Unravelling the fetal origins hypothesis: is there really an inverse association between birthweight and subsequent blood pressure? Lancet (2002) 5.91

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ (2013) 5.78

Aircraft noise and cardiovascular disease near Heathrow airport in London: small area study. BMJ (2013) 5.74

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63

Efficacy and safety of epoetin alfa in critically ill patients. N Engl J Med (2007) 5.63

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60

Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet (2008) 5.55

A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet (2008) 5.49

Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet (2009) 5.43

Human metabolic phenotype diversity and its association with diet and blood pressure. Nature (2008) 5.41

Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA (2009) 5.32

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet (2004) 5.19

Salt intakes around the world: implications for public health. Int J Epidemiol (2009) 5.05

Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet (2008) 4.69

Size matters: just how big is BIG?: Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol (2008) 4.53

Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies. Lancet (2010) 4.46

A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels. Science (2008) 4.38

Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: the MRC spine stabilisation trial. BMJ (2005) 4.27

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. Lancet (2010) 4.23

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet (2005) 4.20

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10

Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet (2007) 4.09

Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08

The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak (2009) 4.05

Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA (2007) 4.03

New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85

Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect (2004) 3.81

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79

Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76

Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75

Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology (2003) 3.59

The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv Res (2009) 3.50

Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet (2011) 3.46

Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature (2012) 3.41

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA (2010) 3.34

Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart (2011) 3.29

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am J Hum Genet (2005) 3.20

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Blood pressure and the global burden of disease 2000. Part II: estimates of attributable burden. J Hypertens (2006) 3.12

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study. Circulation (2012) 2.90

SLC2A9 is a high-capacity urate transporter in humans. PLoS Med (2008) 2.87

China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol (2011) 2.82

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72

Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol (2002) 2.70

Cohort profile: the Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol (2005) 2.70

Fibrinogen and coronary heart disease: test of causality by 'Mendelian randomization'. Int J Epidemiol (2006) 2.68

Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people. BMJ (2006) 2.67

Why New Zealand must rapidly halve its greenhouse gas emissions. N Z Med J (2009) 2.67

The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. Eur Heart J (2008) 2.65

Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc (2010) 2.60

A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60

Sex determination and gonadal development in mammals. Physiol Rev (2007) 2.60

Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature (2011) 2.59